共 20 条
[5]
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes The SURPASS-5 Randomized Clinical Trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2022, 327 (06)
:534-545
[8]
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
[J].
DIABETES OBESITY & METABOLISM,
2020, 22 (06)
:938-946